Medicus Pharma Submits Orphan Drug Designation Application to U.S. FDA for SkinJect® in Gorlin Syndrome

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. DFTX
6. GOOGL
7. APGE
8. MU
9. IBM
10. HOOD

Go back to Medicus Pharma Submits Orphan Drug Designation Application to U.S. FDA for SkinJect® in Gorlin Syndrome
(NASDAQ: MDCX) Delayed: 0.45 -0.01 (2.17%)
Previous Close $0.46    52 Week High $ 
Open $0.46    52 Week Low $ 
Day High $0.46    P/E N/A 
Day Low $0.40    EPS $ 
Volume 2,848,166